NASDAQ:RIGL | Insider Transactions | RIGEL PHARMACEUTICALS INC

RIGL Insider Transactions

145 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.

RIGL insiders transaction timeline

PurchaseSale
2007-05-29: 1 purchase — Grossbard Elliott B2007-08-09: 7 purchases — Goodwin Bradford S2010-11-03: 28 sales — DEERFIELD MANAGEMENT CO /NY, DEERFIELD CAPITAL LP, DEERFIELD INTERNATIONAL LTD and 4 more2011-05-26: 28 purchases — DEERFIELD MANAGEMENT CO /NY, DEERFIELD CAPITAL LP, DEERFIELD INTERNATIONAL LTD and 4 more2012-06-19: 4 sales — PAYAN DONALD G2012-08-07: 4 sales — Maynard Ryan D2012-09-07: 2 sales — Maynard Ryan D2012-09-10: 1 sale — Maynard Ryan D2012-09-12: 1 sale — Maynard Ryan D2012-09-13: 1 sale — VANCE DOLLY2013-06-07: 12 purchases — BIOTECHNOLOGY VALUE FUND L P, BVF PARTNERS L P/IL, BVF INC/IL and 3 more2013-11-19: 12 sales — BIOTECHNOLOGY VALUE FUND L P, BVF PARTNERS L P/IL, BVF INC/IL and 3 more2014-02-24: 1 sale — PAYAN DONALD G2014-09-03: 1 sale — PAYAN DONALD G2014-12-18: 2 sales — VANCE DOLLY2015-04-01: 1 sale — PAYAN DONALD G2015-06-10: 1 sale — PAYAN DONALD G2016-08-30: 1 sale — PAYAN DONALD G2017-01-03: 1 sale — Duliege Anne-Marie2017-07-05: 1 sale — Duliege Anne-Marie2017-11-03: 1 sale — Maynard Ryan D2018-04-20: 1 sale — Duliege Anne-Marie2018-07-02: 1 sale — Duliege Anne-Marie2018-08-17: 1 purchase — RODRIGUEZ RAUL R2018-08-23: 1 purchase — Mayer Eldon C. III2018-09-04: 1 sale — Duliege Anne-Marie2018-09-10: 1 purchase — Mayer Eldon C. III2018-09-11: 1 purchase — Mayer Eldon C. III2018-09-17: 2 sales — Duliege Anne-Marie2018-10-12: 1 sale — Cabatuan Nelson2019-05-22: 2 purchases — Schorno Dean L2022-06-09: 1 purchase — RODRIGUEZ RAUL R2023-02-02: 3 sales — Santos David A, Schorno Dean L, Dummer Wolfgang2023-02-06: 1 sale — RODRIGUEZ RAUL R2024-02-02: 3 sales — Santos David A, Schorno Dean L, RODRIGUEZ RAUL R2024-02-05: 3 sales — Santos David A, Schorno Dean L, RODRIGUEZ RAUL R2025-02-04: 4 sales — Schorno Dean L, Santos David A, RODRIGUEZ RAUL R and 1 more2025-02-05: 4 sales — Schorno Dean L, Santos David A, RODRIGUEZ RAUL R and 1 more2026-02-20: 1 sale — MOOS WALTER H2026-05-26: 1 sale — Ali-Jackson Kamil2026-06-22: 1 sale — Ali-Jackson Kamil2007-05-292026-06-22
Insider profileRoleDateTransactionSharesPrice
Ali-Jackson KamilDirector2026-06-22Sale2,500.0$35.0
Ali-Jackson KamilDirector2026-05-26Sale2,500.0$29.17
MOOS WALTER HDirector2026-02-20Sale4,000.0$36.36
Schorno Dean LEVP & Chief Financial Officer2025-02-05Sale1,734.0$21.93
Santos David AEVP, Chief Commercial Officer2025-02-05Sale1,796.0$21.93
RODRIGUEZ RAUL RCEO, President2025-02-05Sale4,400.0$21.93
Furey Raymond J.EVP, GC, CCO & Corp Sec2025-02-05Sale1,339.0$21.93
Schorno Dean LEVP & Chief Financial Officer2025-02-04Sale2,036.0$20.92
Santos David AEVP, Chief Commercial Officer2025-02-04Sale2,125.0$20.92
RODRIGUEZ RAUL RCEO, President2025-02-04Sale4,952.0$20.92
Furey Raymond J.EVP, GC, CCO & Corp Sec2025-02-04Sale1,448.0$20.92
Santos David AEVP, Chief Commercial Officer2024-02-05Sale8,918.0$1.14
Schorno Dean LEVP & Chief Financial Officer2024-02-05Sale7,027.0$1.14
RODRIGUEZ RAUL RCEO, President2024-02-05Sale30,545.0$1.14
Santos David AEVP, Chief Commercial Officer2024-02-02Sale5,601.0$1.13
Schorno Dean LEVP & Chief Financial Officer2024-02-02Sale5,601.0$1.13
RODRIGUEZ RAUL RCEO, President2024-02-02Sale22,349.0$1.13
RODRIGUEZ RAUL RCEO, President2023-02-06Sale20,340.0$1.75
Santos David AEVP, Chief Commercial Officer2023-02-02Sale5,388.0$1.66
Schorno Dean LEVP & Chief Financial Officer2023-02-02Sale5,389.0$1.66
Dummer WolfgangEVP & CMO2023-02-02Sale5,389.0$1.66
RODRIGUEZ RAUL RCEO, President2022-06-09Purchase1,000,000.0$0.69
Schorno Dean LEVP &Chief Financial Officer2019-05-22Purchase3,274.0$2.13
Schorno Dean LEVP &Chief Financial Officer2019-05-22Purchase46,726.0$2.13
Cabatuan NelsonPrincipal Accounting Officer2018-10-12Sale10,000.0$3.12
Duliege Anne-MarieEVP & Chief Medical Officer2018-09-17Sale37,500.0$3.5
Duliege Anne-MarieEVP & Chief Medical Officer2018-09-17Sale115,500.0$3.5
Mayer Eldon C. IIIEVP & Chief Commercial Officer2018-09-11Purchase50,000.0$3.23
Mayer Eldon C. IIIEVP & Chief Commercial Officer2018-09-10Purchase50,000.0$3.28
Duliege Anne-MarieEVP & Chief Medical Officer2018-09-04Sale16,500.0$3.51
Mayer Eldon C. IIIEVP & Chief Commercial Officer2018-08-23Purchase100,000.0$2.82
RODRIGUEZ RAUL RCEO, President2018-08-17Purchase114,000.0$2.63
Duliege Anne-MarieEVP & Chief Medical Officer2018-07-02Sale5,000.0$2.79
Duliege Anne-MarieEVP & Chief Medical Officer2018-04-20Sale5,000.0$4.11
Maynard Ryan DEVP & CFO2017-11-03Sale100,000.0$3.9
Duliege Anne-MarieChief Medical Officer2017-07-05Sale5,000.0$2.69
Duliege Anne-MarieChief Medical Officer2017-01-03Sale5,000.0$2.41
PAYAN DONALD GEVP, Pres. Discovery&Research2016-08-30Sale5,303.0$4.0
PAYAN DONALD GEVP, Pres. Discovery&Research2015-06-10Sale41,666.0$3.68
PAYAN DONALD GEVP, Pres. Discovery&Research2015-04-01Sale10,000.0$3.75
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.2014-12-18Sale1,000.0$2.22
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.2014-12-18Sale1,000.0$2.22
PAYAN DONALD GEVP, Pres. Discovery&Research2014-09-03Sale20,000.0$2.56
PAYAN DONALD GEVP, Pres. Discovery&Research2014-02-24Sale20,000.0$3.71
BIOTECHNOLOGY VALUE FUND L POther2013-11-19Sale153,056.0$2.64
BVF PARTNERS L P/ILTenPercentOwner2013-11-19Sale153,056.0$2.64
BVF INC/ILTenPercentOwner2013-11-19Sale153,056.0$2.64
BIOTECHNOLOGY VALUE FUND II LPOther2013-11-19Sale153,056.0$2.64
BVF INVESTMENTS LLCOther2013-11-19Sale153,056.0$2.64
LAMPERT MARK NTenPercentOwner2013-11-19Sale153,056.0$2.64
BIOTECHNOLOGY VALUE FUND L POther2013-11-19Sale331,566.0$2.64
BVF PARTNERS L P/ILTenPercentOwner2013-11-19Sale331,566.0$2.64
BVF INC/ILTenPercentOwner2013-11-19Sale331,566.0$2.64
BIOTECHNOLOGY VALUE FUND II LPOther2013-11-19Sale331,566.0$2.64
BVF INVESTMENTS LLCOther2013-11-19Sale331,566.0$2.64
LAMPERT MARK NTenPercentOwner2013-11-19Sale331,566.0$2.64
BIOTECHNOLOGY VALUE FUND L POther2013-06-07Purchase8,102.0$3.47
BVF PARTNERS L P/ILTenPercentOwner2013-06-07Purchase8,102.0$3.47
BVF INC/ILTenPercentOwner2013-06-07Purchase8,102.0$3.47
BIOTECHNOLOGY VALUE FUND II LPOther2013-06-07Purchase8,102.0$3.47
BVF INVESTMENTS LLCOther2013-06-07Purchase8,102.0$3.47
LAMPERT MARK NTenPercentOwner2013-06-07Purchase8,102.0$3.47
BIOTECHNOLOGY VALUE FUND L POther2013-06-07Purchase24,598.0$3.47
BVF PARTNERS L P/ILTenPercentOwner2013-06-07Purchase24,598.0$3.47
BVF INC/ILTenPercentOwner2013-06-07Purchase24,598.0$3.47
BIOTECHNOLOGY VALUE FUND II LPOther2013-06-07Purchase24,598.0$3.47
BVF INVESTMENTS LLCOther2013-06-07Purchase24,598.0$3.47
LAMPERT MARK NTenPercentOwner2013-06-07Purchase24,598.0$3.47
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.2012-09-13Sale4,151.0$10.43
Maynard Ryan DEVP & CFO2012-09-12Sale23,302.0$10.67
Maynard Ryan DEVP & CFO2012-09-10Sale17,586.0$10.52
Maynard Ryan DEVP & CFO2012-09-07Sale23,302.0$10.67
Maynard Ryan DEVP & CFO2012-09-07Sale34,112.0$10.55
Maynard Ryan DEVP & CFO2012-08-07Sale300.0$10.63
Maynard Ryan DEVP & CFO2012-08-07Sale600.0$10.62
Maynard Ryan DEVP & CFO2012-08-07Sale100.0$10.61
Maynard Ryan DEVP & CFO2012-08-07Sale700.0$10.6
PAYAN DONALD GEVP, Pres. Discovery&Research2012-06-19Sale100.0$8.71
PAYAN DONALD GEVP, Pres. Discovery&Research2012-06-19Sale9,700.0$8.7
PAYAN DONALD GEVP, Pres. Discovery&Research2012-06-19Sale100.0$8.72
PAYAN DONALD GEVP, Pres. Discovery&Research2012-06-19Sale100.0$8.75
DEERFIELD MANAGEMENT CO /NYTenPercentOwnerOther2011-05-26Purchase301,424.0$8.0
DEERFIELD CAPITAL LPTenPercentOwnerOther2011-05-26Purchase301,424.0$8.0
DEERFIELD INTERNATIONAL LTDTenPercentOwnerOther2011-05-26Purchase301,424.0$8.0
DEERFIELD PARTNERS, LPTenPercentOwnerOther2011-05-26Purchase301,424.0$8.0
Flynn James ETenPercentOwnerOther2011-05-26Purchase301,424.0$8.0
Deerfield Special Situations Fund, L.P.TenPercentOwnerOther2011-05-26Purchase301,424.0$8.0
Deerfield Special Situations Fund International LTDTenPercentOwnerOther2011-05-26Purchase301,424.0$8.0
DEERFIELD MANAGEMENT CO /NYTenPercentOwnerOther2011-05-26Purchase229,252.0$8.0
DEERFIELD CAPITAL LPTenPercentOwnerOther2011-05-26Purchase229,252.0$8.0
DEERFIELD INTERNATIONAL LTDTenPercentOwnerOther2011-05-26Purchase229,252.0$8.0
DEERFIELD PARTNERS, LPTenPercentOwnerOther2011-05-26Purchase229,252.0$8.0
Flynn James ETenPercentOwnerOther2011-05-26Purchase229,252.0$8.0
Deerfield Special Situations Fund, L.P.TenPercentOwnerOther2011-05-26Purchase229,252.0$8.0
Deerfield Special Situations Fund International LTDTenPercentOwnerOther2011-05-26Purchase229,252.0$8.0
DEERFIELD MANAGEMENT CO /NYTenPercentOwnerOther2011-05-26Purchase72,800.0$8.0
DEERFIELD CAPITAL LPTenPercentOwnerOther2011-05-26Purchase72,800.0$8.0
DEERFIELD INTERNATIONAL LTDTenPercentOwnerOther2011-05-26Purchase72,800.0$8.0
DEERFIELD PARTNERS, LPTenPercentOwnerOther2011-05-26Purchase72,800.0$8.0
Flynn James ETenPercentOwnerOther2011-05-26Purchase72,800.0$8.0